Skip to content

Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs

Predictors of Early Success From Circumferential Compression STITCH Meniscal Repairs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03097744
Acronym
STITCHRetro
Enrollment
23
Registered
2017-03-31
Start date
2017-02-01
Completion date
2018-04-20
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Medial Meniscus Tears, Meniscus Disorder, Meniscus Lesion, Meniscus; Rupture, Bucket Handle

Keywords

Lateral Meniscus Tear, Medial Meniscus Tear

Brief summary

This is a retrospective study of meniscal tear repairs at least one-year post repair status. All patients were treated with Ceterix NovoStitch devices. The primary objectives of this study are to assess the clinical repair success rate via reoperation and PROs at greater than 12 months.

Detailed description

The study is a retrospective, non-randomized, single-group assignment, open-label study of repairs of meniscal tears status post repair. The following clinical efficacy endpoints will be evaluated at greater than 12 months: * Reoperation rate * Validated patient-reported outcomes measures * Contribution of the following retrospective covariates on failure and outcomes when available: Type of tear, Location of tear (lateral versus medial), Chronicity of symptoms, Nature of tear (degenerative versus traumatic), Length of tear, Patient age, Patient gender, Length of rehabilitation protocol, Performance of trephination, Inclusion of biologic enhancement, Meniscal repair alone versus meniscal repair combined with ACL reconstruction.

Interventions

DEVICECeterix NovoStitch

The device allows the physician to place a circumferential compression stitch around meniscal tears. This stitch is placed by passing suture from the tibial side to the femoral side of the meniscus and across the tear. This allows compression across the entire tear surface.

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Able and willing to give consent by voluntarily providing written informed consent in accordance with governing Institutional Review Board (IRB)/Independent Ethics Committee (IEC) requirements, local regulations, and Health Insurance Portability and Accountability Act (HIPAA) Authorization (or equivalent if locally applicable) * In the opinion of the Investigator are able to comply with study-required follow-up

Exclusion criteria

* Post-operative interval \<1year * Concurrent bony fractures * Post-operative reinjury (except the meniscus) * Pre-operative arthritis grade 3 or higher on modified outerbridge * Knee surgery prior to meniscus repair surgery * Any kind of infection

Design outcomes

Primary

MeasureTime frameDescription
Reoperation RateJanuary 2015-February 2016Data provided by patients
Validated patient-reported outcomes measuresJanuary 2015-February 2016IKDC Subjective
Contribution of the following retrospective covariates on failure and outcomes when availableJanuary 2015-February 2016Type of tear Location of tear (lateral versus medial), Chronicity of symptoms, Nature of tear (degenerative versus traumatic), Length of tear, Patient age, Patient gender, Length of rehabilitation protocol, Performance of trephination, Inclusion of biologic enhancement, Meniscal repair alone versus meniscal repair combined with ACL reconstruction

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026